Profile
Mr. Ronald Loggers is Chairman at ISA Pharmaceuticals BV.
He is on the Board of Directors at Schreiner Luchtvaart Groep BV.
Mr. Loggers was previously employed as a Managing Director by Multifund BV.
Mr. Loggers received his graduate degree from the Delft University of Technology and an MBA from INSEAD.
Former positions of Ronald J. Loggers
Companies | Position | End |
---|---|---|
Multifund BV
Multifund BV Investment ManagersFinance Multifund BV is an independent investment adviser headquartered in Reeuwijk, Netherlands and was founded in 2002. Multifund manages diversified assets. | Chief Executive Officer | 30/06/2014 |
Schreiner Luchtvaart Groep BV | Director/Board Member | 27/04/2014 |
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Chief Executive Officer | - |
Training of Ronald J. Loggers
INSEAD | Masters Business Admin |
Delft University of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Schreiner Luchtvaart Groep BV | Consumer Durables |
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Health Technology |
Multifund BV
Multifund BV Investment ManagersFinance Multifund BV is an independent investment adviser headquartered in Reeuwijk, Netherlands and was founded in 2002. Multifund manages diversified assets. | Finance |
- Stock Market
- Insiders
- Ronald J. Loggers